Profilo

Mr. Kyle M.
Lauzon
is a Director-Institutional Sales Group at C.
K.
Cooper & Co. He joined C.
K.
Cooper & Co. in October 2009.
He has 18 years experience in the financial services sector and for the last 10 years has been exclusively focused on institutional research sales in the healthcare and technology sectors.
Most recently, he was a Managing Director of Institutional Equity Sales at Biologic Investment Research, LLC.
Prior to joining Biologic Investment Research, LLC, Mr. Lauzon was the Director of Institutional Equity Sales for Dawson James Securities.
At Dawson James, he was responsible for building out the institutional equities distribution and trading platforms.
Mr. Lauzon also developed and managed regular expert led conference calls, surveys as well as both deal and non-deal corporate road shows.
Mr. Lauzon received multiple awards while at Dawson James in 2006 & 2007 for top institutional production.
In late 2001, Mr. Lauzon joined Sterling Financial Investment Group as an institutional sales representative where by the end of 2002 he had become the desk's top producer and was awarded "MVP" status for his exceptional performance.He holds series 7, 24, and 63 securities licenses.

Precedenti posizioni note di Kyle M. Lauzon

SocietàPosizioneFine
Vendite Istituzionali 01/11/2010
Trading-Equity 30/09/2009
Vendite Istituzionali 31/12/2008
Vendite Istituzionali -
Vedi nel dettaglio l'esperienza di Kyle M. Lauzon

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kyle M. Lauzon

Relazioni

11

Relazioni di 1° grado

4

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private4

Finance

Finance

Finance

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Kyle M. Lauzon